TELUS Partners with TD Securities and Jefferies for TELUS Health Monetisation Strategy
In a significant step forward for TELUS Corporation, the company has announced the engagement of TD Securities Inc. and Jefferies Securities, Inc. as financial advisors to fine-tune a monetisation strategy for its TELUS Health division. This strategic move is aimed at bolstering TELUS Health's operational capabilities while exploring avenues for potential partnerships that could further enhance growth. TELUS Health now serves over 160 million lives across more than 200 countries, demonstrating its substantial footprint in the global healthcare market. Recent reports indicate the division has generated impressive year-to-date results, with operating revenues of $1.5 billion, EBITDA of $258 million, and cash flow of $99 million as of Q3 2025.
Darren Entwistle, President and CEO of TELUS, emphasized the urgency and significance of this move, stating, 'Our engagement of TD Securities and Jefferies demonstrates progress towards executing on commitments to the investment community.' He further elaborated that these advisors bring strategic expertise and necessary networks that can aid in accelerating TELUS Health's ongoing development momentum.
The TELUS Health division is experiencing a pivotal growth phase, driven by its commitment to innovative healthcare solutions. This momentum has led to speculation about the potential for strategic partnerships that could leverage complementary resources, skills, and customer bases to maximize value creation.
Entwistle pointed out that TELUS Health's capabilities extend beyond Canada, rapidly expanding to encompass a diverse range of AI products that meet emerging market demands across various sectors. 'We believe that identifying a strategic partner for TELUS Health will be a vital step in achieving our long-term growth objectives,' he asserted.
This monetisation strategy also ties into TELUS’ broader goals of achieving a more sustainable financial structure. TELUS is making strides to reduce its net debt to adjusted EBITDA ratio, currently projected at approximately 3.4 times for 2025, with aims to lower it to about 3.3 times by the end of 2026, and further to 3.0 times by 2027. This strategy highlights the company's disciplined approach to capital allocation as part of its commitment to value creation for its varied stakeholders.
The engagement of TD Securities and Jefferies aligns with TELUS’ past communications regarding its deleveraging strategy, which aims to enhance cash flow projections while systematically addressing operations for greater efficiency. The company has set ambitious targets, aiming for a compounded annual growth rate of at least 10% through 2028, underpinned by support from various monetisation opportunities.
Though forward-looking statements form part of this engagement announcement, investors are advised to exercise caution, recognizing the inherent uncertainty in future market performance and potential partnerships. Factors that might affect outcomes include economic conditions, evolving market dynamics, and internal operational capabilities.
In conclusion, TELUS Health is at a crucial crossroads, with its CEO expressing optimism about the division's prospects while defining a clear path forward. As TELUS forges ahead, the anticipated partnerships and strategic alignments are expected to enhance the company’s overall health service impact, potentially shaping the future of healthcare technology on a global scale.
For more information about TELUS and its initiatives, visit their official website or follow their media updates on social media platforms. TELUS remains committed to its ethos of delivering superior service and value to its customers while fostering a commitment to community and healthcare improvements worldwide.
Darren Entwistle, President and CEO of TELUS, emphasized the urgency and significance of this move, stating, 'Our engagement of TD Securities and Jefferies demonstrates progress towards executing on commitments to the investment community.' He further elaborated that these advisors bring strategic expertise and necessary networks that can aid in accelerating TELUS Health's ongoing development momentum.
The TELUS Health division is experiencing a pivotal growth phase, driven by its commitment to innovative healthcare solutions. This momentum has led to speculation about the potential for strategic partnerships that could leverage complementary resources, skills, and customer bases to maximize value creation.
Entwistle pointed out that TELUS Health's capabilities extend beyond Canada, rapidly expanding to encompass a diverse range of AI products that meet emerging market demands across various sectors. 'We believe that identifying a strategic partner for TELUS Health will be a vital step in achieving our long-term growth objectives,' he asserted.
This monetisation strategy also ties into TELUS’ broader goals of achieving a more sustainable financial structure. TELUS is making strides to reduce its net debt to adjusted EBITDA ratio, currently projected at approximately 3.4 times for 2025, with aims to lower it to about 3.3 times by the end of 2026, and further to 3.0 times by 2027. This strategy highlights the company's disciplined approach to capital allocation as part of its commitment to value creation for its varied stakeholders.
The engagement of TD Securities and Jefferies aligns with TELUS’ past communications regarding its deleveraging strategy, which aims to enhance cash flow projections while systematically addressing operations for greater efficiency. The company has set ambitious targets, aiming for a compounded annual growth rate of at least 10% through 2028, underpinned by support from various monetisation opportunities.
Though forward-looking statements form part of this engagement announcement, investors are advised to exercise caution, recognizing the inherent uncertainty in future market performance and potential partnerships. Factors that might affect outcomes include economic conditions, evolving market dynamics, and internal operational capabilities.
In conclusion, TELUS Health is at a crucial crossroads, with its CEO expressing optimism about the division's prospects while defining a clear path forward. As TELUS forges ahead, the anticipated partnerships and strategic alignments are expected to enhance the company’s overall health service impact, potentially shaping the future of healthcare technology on a global scale.
For more information about TELUS and its initiatives, visit their official website or follow their media updates on social media platforms. TELUS remains committed to its ethos of delivering superior service and value to its customers while fostering a commitment to community and healthcare improvements worldwide.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.